Risk of death following application of paclitaxel‐coated balloons and stents in the femoropopliteal artery of the leg: a systematic review and meta‐analysis of …
Background Several randomized controlled trials (RCT s) have already shown that
paclitaxel‐coated balloons and stents significantly reduce the rates of vessel restenosis and …
paclitaxel‐coated balloons and stents significantly reduce the rates of vessel restenosis and …
An update on methods for revascularization and expansion of the TASC lesion classification to include below-the-knee arteries: a supplement to the Inter-Society …
TASC Steering Committee*, MR Jaff… - Journal of …, 2015 - journals.sagepub.com
The Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC)
guidelines were last updated in 2007 (TASC II) and represented the collaboration of …
guidelines were last updated in 2007 (TASC II) and represented the collaboration of …
[HTML][HTML] ESVM Guideline on peripheral arterial disease
U Frank, S Nikol, J Belch, V Boc, M Brodmann… - Vasa, 2019 - econtent.hogrefe.com
The European Society of Vascular Medicine (ESVM) was founded in Paris in 2012 as a
confederation of already existing and emerging European societies of vascular medicine. At …
confederation of already existing and emerging European societies of vascular medicine. At …
Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month …
G Tepe, J Laird, P Schneider, M Brodmann… - Circulation, 2015 - Am Heart Assoc
Background—Drug-coated balloons (DCBs) have shown promise in improving the
outcomes for patients with peripheral artery disease. We compared a paclitaxel-coated …
outcomes for patients with peripheral artery disease. We compared a paclitaxel-coated …
Directional atherectomy followed by a paclitaxel-coated balloon to inhibit restenosis and maintain vessel patency: twelve-month results of the DEFINITIVE AR study
T Zeller, R Langhoff, KJ Rocha-Singh… - Circulation …, 2017 - Am Heart Assoc
Background—Studies assessing drug-coated balloons (DCB) for the treatment of
femoropopliteal artery disease are encouraging. However, challenging lesions, such as …
femoropopliteal artery disease are encouraging. However, challenging lesions, such as …
Angioplasty of femoral-popliteal arteries with drug-coated balloons: 5-year follow-up of the THUNDER trial
G Tepe, B Schnorr, T Albrecht, K Brechtel… - JACC: Cardiovascular …, 2015 - jacc.org
Objectives: The purpose of this study was to evaluate the 5-year follow-up (FU) data of the
THUNDER (Local Taxan With Short Time Contact for Reduction of Restenosis in Distal …
THUNDER (Local Taxan With Short Time Contact for Reduction of Restenosis in Distal …
Lower extremity revascularization using directional atherectomy: 12-month prospective results of the DEFINITIVE LE study
JF McKinsey, T Zeller, KJ Rocha-Singh, MR Jaff… - JACC: Cardiovascular …, 2014 - jacc.org
Objectives: The aim of this study was to assess the safety and effectiveness of directional
atherectomy (DA) for endovascular treatment of peripheral arterial disease (PAD) in …
atherectomy (DA) for endovascular treatment of peripheral arterial disease (PAD) in …
[HTML][HTML] Editor's choice–risk of major amputation following application of paclitaxel coated balloons in the lower limb arteries: a systematic review and meta-analysis of …
K Katsanos, S Spiliopoulos, U Teichgräber… - European Journal of …, 2022 - Elsevier
Objective There have been concerns about the long term safety of paclitaxel coated devices
in the lower limbs. A formal systematic review and meta-analysis of randomised controlled …
in the lower limbs. A formal systematic review and meta-analysis of randomised controlled …
Drug-coated balloon therapy in coronary and peripheral artery disease
Nonstent-based local drug delivery during percutaneous intervention offers potential for
sustained antirestenotic efficacy without the limitations of permanent vascular implants …
sustained antirestenotic efficacy without the limitations of permanent vascular implants …
Paclitaxel-coated balloon angioplasty versus drug-eluting stenting for the treatment of infrapopliteal long-segment arterial occlusive disease: the IDEAS randomized …
Objectives: This study sought to report the results of a prospective randomized controlled
trial comparing paclitaxel-coated balloons (PCB) versus drug-eluting stents (DES) in long …
trial comparing paclitaxel-coated balloons (PCB) versus drug-eluting stents (DES) in long …